HOXC9 and neoplasm: As shown in Figure 7B, a notable reduction in tumor growth rate was evident within the Hoxc9 knockdown group compared to the control group, both under IgG isotype conditions (P<0.05) and following PD-1 blockade intervention (P<0.01) (the tumor models photograph was in Supplementary Figure 2).